Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
for
Urinary Retention
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: Male
Age: 50+
Code: NCT03609580
Phase1, Phase2, Recruiting
Pancreatic Cancer Early Detection Consortium
for
Pancreas Cancer, Pancreas Cyst,
Location: Hackensack NJ, New York NY, White Plains NY,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 18 - 70+
Code: NCT04970056
Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Hackensack NJ, New Haven CT, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase1, Phase2, Recruiting
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
for
Peripheral T-cell Lymphoma
Location: Hackensack NJ, Greenville SC, Louisville KY, Atlanta GA,
Sponsor: CerRx, Inc.
Sex: All
Age: 18+
Code: NCT02495415
Phase2, Recruiting
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
for
Alzheimer Disease
Location: Hackensack NJ
Sponsor: Herrick Medical LLC
Sex: All
Age: 50 - 70+
Code: NCT05295615
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
First in Human, Dose Escalation Study of AN4005
for
Advanced Solid Tumor, Advanced Lymphoma
Location: Hackensack NJ, The Bronx NY, Fairfax VA, Greenville SC
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT04999384
Phase1, Recruiting
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Location: Hackensack NJ, New Hyde Park NY, Neptune City NJ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 1 - 17
Code: NCT05003986
Phase2, Recruiting
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Hackensack NJ, New Haven CT, Pittsburgh PA, Canton OH,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase1, Phase2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Hackensack NJ, New Brunswick NJ, Stony Brook NY,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase3, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Hackensack NJ, The Bronx NY, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors